Bone mineral density and nutritional status in children with chronic inflammatory bowel disease

A M Boot1, J Bouquet, E P Krenning

  • 1Department of Paediatrics, Erasmus University, Rotterdam, The Netherlands.

Gut
|April 16, 1998
PubMed

Insights

Children with inflammatory bowel disease (IBD) have lower bone mineral density (BMD). Crohn's disease patients face a higher risk of osteopenia than ulcerative colitis patients, with corticosteroid use and nutrition impacting BMD.

Area of Science:

  • Pediatric Endocrinology
  • Gastroenterology
  • Metabolic Bone Disease

Background:

  • Osteoporosis is a known complication in adult inflammatory bowel disease (IBD) patients.
  • Limited data exists on bone health in pediatric IBD populations.
  • Evaluating bone mineral density (BMD) in children with IBD is crucial.

Purpose of the Study:

  • To assess bone mineral density (BMD) in children diagnosed with inflammatory bowel disease (IBD).
  • To evaluate the nutritional status and identify determinants of BMD in pediatric IBD patients.
  • To compare BMD between children with Crohn's disease and ulcerative colitis.

Main Methods:

  • Dual-energy X-ray absorptiometry (DXA) was used to measure lumbar spine and total body BMD and body composition in 55 children (ages 4-18).
  • Bioelectrical impedance analysis (BIA) assessed lean body mass.
  • Measurements were taken at baseline and annually for two years in a subset of patients.

Main Results:

  • Children with IBD exhibited significantly lower mean lumbar spine and total body BMD standard deviation scores (SDS) compared to normal values.
  • Decreased height SDS and body mass index SDS were observed; bone maturation delay did not explain the reduced BMD.
  • Cumulative corticosteroid (prednisolone) dose negatively correlated with BMD, while body mass index SDS positively correlated with total body BMD. Crohn's disease patients had lower BMD than ulcerative colitis patients, even after adjusting for prednisolone.
  • Longitudinal data showed a negative correlation between cumulative prednisolone dose and changes in BMD.

Conclusions:

  • Pediatric patients with inflammatory bowel disease (IBD) demonstrate reduced bone mineral density (BMD).
  • Children with Crohn's disease have a greater risk of developing osteopenia compared to those with ulcerative colitis.
  • Corticosteroid therapy and nutritional status are significant factors influencing BMD in pediatric IBD.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...